Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration ‐resistant prostate cancer

BJU International, EarlyView.

Source: BJU International - September 5, 2018 Category: Urology & Nephrology Authors: Charlotte Fenioux , Christophe Louvet , Emilie Charton , Francois Rozet , Stanislas Ropert , Dominique Prapotnich , Eric Barret , Rafael Sanchez ‐Salas , Annick Mombet , Nathalie Cathala , Marie‐Liesse Joulia , Jean‐Luc Molito Source Type: research